Log In
Print this Print this

TroVax (OXB-301)

  Manage Alerts
Collapse Summary General Information
Company Oxford BioMedica plc
DescriptionModified vaccinia Ankara (MVA) against 5T4
Molecular Target Oncofetal antigen 5T4
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today